NEW YORK, March 22, 2016 /PRNewswire/ -- This report analyzes the worldwide markets for Kidney Stone Management Devices in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 50 companies including many key and niche players such as -
Allengers Medical Systems Ltd.,
Bard Medical Division
Boston Scientific Corporation
Coloplast Group
Cook Medical
Read the full report: http://www.reportlinker.com/p03704481-summary/view-report.html
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3 Lithotripsy Devices/Lithotripters I-4 Stone Removal Devices..............I-4 Ureteral Stents.............. I-4
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW.............. II-1 Growing Urolithiasis Incidence Drives Kidney Stone Management Devices Demand.............. II-1 Products in the Kidney Stone Management Devices Market by Select Leading Player..............II-3 Emerging Countries Bode Higher Growth Prospects II-3 Market Drivers.............. II-4 Market Restraints.............. II-5 Incidence and Prevalence of Urolithiasis Increases Worldwide II-5
2. GLOBAL KIDNEY STONE MANAGEMENT LANDSCAPE II-6 Available Treatment Modalities II-6 A Brief Comparison of Techniques II-6 Minimally Invasive and Non-Invasive Procedures Hog the Limelight II-7 Extracorporeal Lithotripsy Dominates, while Intracorporeal Procedures Gain Popularity..............II-7 Competitive Landscape..............II-8
3. EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL) II-9 ESWL - The Gold Standard in Kidney Stone Treatment II-9 Major Indications and Contra-Indications of ESWL II-9 Non-Invasive Nature - A Major Driver for ESWL II-9 Evolution Stalls in Efficacy of ESWL Technology II-10 ESWL Market Typifies Intensified Competition II-10 Electroconductive Technology - A Breakthrough in Shock Wave Therapy.............. II-10 Advancements in Shock Wave Sources II-10 Primary Components in ESWL..............II-11 Shock Wave Generators..............II-11 Focusing Systems..............II-12 Localization Systems..............II-12 Coupling Systems..............II-12
4. INTRACORPOREAL LITHOTRIPSY/ URETEROSCOPIC II-13 Major Indications of Ureteroscopic Procedures II-13 Types of Endoscopic Lithotripsy Devices II-13 Pneumatic Lithotripsy Devices II-13 Ultrasonic Lithotripsy Devices..............II-14 Electrohydraulic Lithotripsy..............II-14 Laser Lithotripsy..............II-14 Holmium Lasers Market to Surge II-15 Technological Advances in Ureteroscopes Engender Superior Treatment Capabilities..............II-15
5. PERCUTANEOUS NEPHROLITHOTOMY (PCNL) II-16 Percutaneous Nephrolithotomy - Ideal Procedure for Removal of Large Stones.............. II-16 Select PCNL Devices and Nephroscopes II-16 Mini-Percutaneous Nephrolithotomy - A New Technique for Smaller Stones.............. II-16 PCNL Equipment.............. II-16 Lithotripsy Devices..............II-16 Nephroscopes.............. II-17 Stone Management Devices..............II-18 Matrix Agents and Sealants Yet to Prove Clinical Efficiency II-18
6. STONE MANAGEMENT DEVICE ACCESSORIES II-19 Rising Demand for Intracorporeal Lithotripters Drives Demand for Accessories.............. II-19 Ureteral Stents - A Major Accessory in Kidney Stone Management II-19 Ureteral Stent Use in ESWL, Mired with Controversies II-19 Synthetic Polymers - The Most Common Biomaterial Used in Ureteral Stents.............. II-19 Design Advances in Ureteral Stents to Minimize Morbidity II-20
7. KIDNEY STONE DISEASE - AN OVERVIEW II-21 Types of Kidney Stones..............II-21 Oxalate Stones.............. II-21 Phosphate Stones.............. II-22 Uric Acid & Urate Stones..............II-22 Cystine Stones.............. II-22 Rare/Uncommon Stone Types..............II-22 Kidney Stone Types & Their Incidence II-22 Evaluation of Kidney Stones..............II-23 Computed Tomography - A Major Technology in the Evaluation of Stones.............. II-23 The Evolution of Kidney Stone Treatment II-23 Treatment Procedures - How they are Done? II-24 Surgery.............. II-24 Extracorporeal Shock Wave Lithotripsy (ESWL) II-24 ESWL-A Breakthrough in Kidney Stone Therapy II-25 Expansion of Indication Area II-26 Intracorporeal Lithotripsy..............II-26 Types of Intracorporeal Lithotripters II-26 Electrohydraulic Lithotripsy (EHL) II-27 Laser Lithotripsy..............II-27 Types of Laser Lithotripters II-27 Holmium Laser Lithotripsy..............II-28 Pros.............. II-28 Cons.............. II-28 Pulsed-Dye Lasers.............. II-28 Alexandrite Lasers..............II-28 Percutaneous Nephrolithotomy..............II-28 Selection of An Appropriate Technique II-29 Factors Affecting Choice of Lithotripters II-29 Conventional Medicines for Kidney Stones II-29 Calcium Stones.............. II-30 Uric Acid Stones.............. II-30 Cystine Stones.............. II-30 Struvite Stones.............. II-30 Natural Remedies.............. II-30 Complementary Therapy..............II-31
8. SELECT PRODUCT LAUNCHES..............II-32 Boston Scientific Rolls Out Single-Use Ureteroscope II-32 Terumo Unveils GLIDEWAY™ Ureteral Access Sheath II-32
9. RECENT INDUSTRY ACTIVITY..............II-33 EDAP Bags Exclusive Distribution Rights for Quanta Litho Laser in Japan.............. II-33 USMD Holdings Sells US Lithotripsy Division to United Medical Systems.............. II-33 HealthTronics Takes Over Management Company II-33 Syneron Medical Inks Agreement with American Medical Systems II-33 MILA International Enters into a Distribution Agreement with Dextronix.............. II-33 SANUWAVE Health Inks Agreement with Premier Shockwave II-34
10. FOCUS ON SELECT GLOBAL PLAYERS II-35 Allengers Medical Systems Ltd. (India) II-35 Bard Medical Division (USA)..............II-35 Boston Scientific Corporation (USA) II-35 Coloplast Group (Denmark)..............II-36 Cook Medical (USA)..............II-36 DirexGroup (Germany)..............II-37 Dornier MedTech (Germany)..............II-37 EDAP TMS SA (France)..............II-37 E.M.S. Electro Medical Systems S.A. (Switzerland) II-38 Lumenis Ltd. (Israel)..............II-38 New Star Lasers, Inc. (USA)..............II-39 Olympus Corporation of the Americas (USA) II-39 Richard Wolf GmbH (Germany)..............II-39 Siemens Medical Solutions USA, Inc. (USA) II-40 Storz Medical AG (Switzerland) II-40
11. GLOBAL MARKET PERSPECTIVE..............II-41 Table 1: World Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin American Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)..............II-41
Table 2: World Historic Review for Kidney Stone Management Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin American Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. II-42
Table 3: World 14-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Share Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin American Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart) II-43
III. MARKET
1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Lifestyle Disorders Causing Increased Incidence of Kidney Stones.............. III-1 Kidney Stone Prevalence Increases among All Groups and Races III-1 Table 4: Urinary Calculus Incidence by Type in the US: Percentage Breakdown of Incidence for Calcium Oxalate + Phosphate, Calcium Oxalate, Magnesium Ammonium Phosphate, Uric Acid, Cystine and Others (includes corresponding Graph/Chart).............. III-2 Healthcare Reforms & Demographic Factors to Influence Urological Devices Market..............III-2 Reimbursement Scenario..............III-3 Table 5: US National Medicare Average Reimbursement for Select Kidney Stone Management Procedures: 2016 & 2015 III-3 Alternative Procedures Gain Popularity, As ESWL Loses Sheen III-4 Safety Concerns Mar ESWL's Popularity III-4 Advancements in Ureteroscopy Devices Set Stage for Higher Adoption.............. III-4 Robust Demand for Holmium Lasers and Ureteral Stents III-4 Increasing Popularity of 'Tubeless' Percutaneous Nephrolithotomy..............III-5 Expanding Patient Population Compels Urologist to Opt for Advanced Devices.............. III-5 Varying Treatment Preference among Urologists III-5 Women Exhibit High Vulnerability to Urolithiasis-related Infections.............. III-6 Global Warming to Expand US Kidney-Stone Belt III-6 Association between Calcium Supplements and Risk of Kidney Stones.............. III-6 Product Launches..............III-7 Strategic Corporate Developments III-8 Focus on Select Major Players..............III-9 B.Market Analytics..............III-11 Table 6: The US Recent Past, Current & Future Analysis for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-11
Table 7: The US Historic Review for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-12
2. CANADA.............. III-13 Market Analysis.............. III-13 Table 8: Canadian Recent Past, Current & Future Analysis for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-13
Table 9: Canadian Historic Review for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-14
3. JAPAN.............. III-15 A.Market Analysis.............. III-15 Table 10: Urinary Calculus Incidence by Type in Japan: Percentage Breakdown of Incidence for Calcium Oxalate + Phosphate, Magnesium Ammonium Phosphate, Calcium Oxalate, Uric Acid, Cystine and Others (includes corresponding Graph/Chart).............. III-15 Strategic Corporate Development III-15 B.Market Analytics..............III-16 Table 11: Japanese Recent Past, Current & Future Analysis for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-16
Table 12: Japanese Historic Review for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-17
4. EUROPE.............. III-18 A.Market Analysis.............. III-18 Rising Incidence and Recurrence of Kidney Stones Propel Market Growth.............. III-18 Stone Fragment Retrieval Devices III-18 B.Market Analytics..............III-19 Table 13: European Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-19
Table 14: European Historic Review for Kidney Stone Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-20
Table 15: European 14-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Share Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart) III-21
4a. FRANCE.............. III-22 A.Market Analysis.............. III-22 EDAP TMS SA - A Key Player..............III-22 B.Market Analytics..............III-23 Table 16: French Recent Past, Current & Future Analysis for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-23
Table 17: French Historic Review for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-24
4b. GERMANY.............. III-25 A.Market Analysis.............. III-25 Minimizing Kidney Stones Recurrence through Fast Analysis III-25 Select Key Players..............III-26 B.Market Analytics..............III-27 Table 18: German Recent Past, Current & Future Analysis for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-27
Table 19: German Historic Review for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-28
4c. ITALY.............. III-29 Market Analysis.............. III-29 Table 20: Italian Recent Past, Current & Future Analysis for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-29
Table 21: Italian Historic Review for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-30
4d. THE UNITED KINGDOM..............III-31 A.Market Analysis.............. III-31 Increasing Kidney Stone Incidence Drives Market Growth III-31 Table 22: Urinary Calculus Incidence by Type in the UK: Percentage Breakdown of Incidence for Calcium Oxalate, Calcium Oxalate + Phosphate, Magnesium Ammonium Phosphate, Uric Acid, Cystine and Others (includes corresponding Graph/Chart).............. III-31 B.Market Analytics..............III-32 Table 23: The UK Recent Past, Current & Future Analysis for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-32
Table 24: The UK Historic Review for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-33
4e. SPAIN.............. III-34 Market Analysis.............. III-34 Table 25: Spanish Recent Past, Current & Future Analysis for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-34
Table 26: Spanish Historic Review for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-35
4f. RUSSIA.............. III-36 Market Analysis.............. III-36 Table 27: Russian Recent Past, Current & Future Analysis for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-36
Table 28: Russian Historic Review for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-37
4g. REST OF EUROPE.............. III-38 A.Market Analysis.............. III-38 Select Key Players..............III-38 B.Market Analytics..............III-39 Table 29: Rest of European Recent Past, Current & Future Analysis for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-39
Table 30: Rest of European Historic Review for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-40
5. ASIA-PACIFIC.............. III-41 A.Market Analysis.............. III-41 Urolithiasis - A Widespread Condition in India III-41 Table 31: Urinary Calculus Incidence by Type in India: Percentage Breakdown of Incidence for Calcium Oxalate, Calcium Oxalate + Phosphate, Magnesium Ammonium Phosphate, Uric Acid, Cystine and Others (includes corresponding Graph/Chart).............. III-41 Growing Medical Tourism Increases Kidney Stone Procedures in India.............. III-42 Select Regional Players..............III-42 B.Market Analytics..............III-43 Table 32: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-43
Table 33: Asia-Pacific Historic Review for Kidney Stone Management Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-44
Table 34: Asia-Pacific 14-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Share Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)..............III-45
6. THE MIDDLE EAST & AFRICA..............III-46 A.Market Analysis.............. III-46 Lumenis Pulse™ 120H Laser Urology Platform from Lumenis III-46 Lumenis Ltd. - A Major Israeli Player III-46 B.Market Analytics..............III-47 Table 35: The Middle East & Africa Recent Past, Current & Future Analysis for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart) III-47
Table 36: The Middle East & Africa Historic Review for Kidney Stone Management Devices Market Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-48
7. LATIN AMERICA.............. III-49 Market Analysis.............. III-49 Table 37: Latin American Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart).............. III-49
Table 38: Latin American Historic Review for Kidney Stone Management Devices by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart) III-50
Table 39: Latin American 14-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Share Breakdown of Revenues for Brazil and Rest of Latin America Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)..............III-51
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 50 (including Divisions/Subsidiaries - 60)
The United States (22) Japan (2) Europe (22) - France (1) - Germany (14) - Rest of Europe (7) Asia-Pacific (Excluding Japan) (11) Middle East (3)
Read the full report: http://www.reportlinker.com/p03704481-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article